Theriva Biologics (TOVX) Treasury Shares (2010 - 2026)

Theriva Biologics (TOVX) has reported Treasury Shares for 5 consecutive years, with $288000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares changed 0.0% year-over-year to $288000.0; the TTM figure through Mar 2026 stood at $288000.0 (changed 0.0% YoY), while the FY2025 annual figure was $288000.0, changed 0.0% from the prior year.
• Treasury Shares held at $288000.0 in Q1 2026 per TOVX's latest filing, from $288000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $16.3 million in Q1 2026 and bottomed at $28809.0 in Q4 2023.
• Historically, Treasury Shares has averaged $2.9 million across 5 years, with a median of $720233.0 in 2023.
• On a YoY basis, Treasury Shares climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
• Theriva Biologics' Treasury Shares stood at $288000.0 in 2022, then changed by 0.0% to $288000.0 in 2023, then changed by 0.0% to $288000.0 in 2024, then changed by 0.0% to $288000.0 in 2025, then changed by 0.0% to $288000.0 in 2026.
• Business Quant data shows TOVX's Treasury Shares at $288000.0 in Q1 2026, $288000.0 in Q4 2025, and $288000.0 in Q3 2025.